When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACST - Acasti Pharma's CaPre flunks late-stage study shares down 60%
Acasti Pharma Inc.
Nano cap Acasti Pharma (NASDAQ:ACST)announces unsuccessful results from a second Phase 3 clinical trial, TRILOGY 2, evaluating CaPre (omega-3 phospholipid) for the treatment of patients with very high levels of triglycerides in the blood (hypertriglyceridemia).
More news on: Acasti Pharma Inc., Healthcare stocks news, Stocks on the move,